UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046773
Receipt number R000053343
Scientific Title If-then Plan for Increasing Physical Activity in Patients with Type 2 Diabetes
Date of disclosure of the study information 2022/02/20
Last modified on 2023/08/03 22:47:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

If-then Plan for Increasing Physical Activity in Patients with Type 2 Diabetes

Acronym

If-then Plan for Increasing Physical Activity in Patients with Type 2 Diabetes

Scientific Title

If-then Plan for Increasing Physical Activity in Patients with Type 2 Diabetes

Scientific Title:Acronym

If-then Plan for Increasing Physical Activity in Patients with Type 2 Diabetes

Region

Japan


Condition

Condition

type2 diabetes

Classification by specialty

Endocrinology and Metabolism Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

It has been reported that exercise therapy, one of the treatments for diabetes mellitus, is often not supervised, and even when supervised, about half of the patients do not continue to exercise. Therefore, in order to maintain and improve glycemic control, it is necessary to provide guidance and intervention methods that promote behavioral change so that patients can continue to exercise. Recently, it has been suggested that the concept of intention to perform may influence changes in behavioral change. In this study, we will examine the effects of exercise instruction using the if-then plan on the amount of physical activity before and after the instruction in patients with type 2 diabetes.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Physical activity before and after hospitalization for 10 days

Key secondary outcomes

Age,gender,physical function,cognitive function,Short Physical Performance Battery,Japanese Montreal Cognitive Assessment,muscle strength,Barthel Index


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

A total of four interventions of 40 minutes each will be conducted during the 8-14 day educational hospitalization.Provide exercise instruction using an if-then plan.

Interventions/Control_2

A total of four interventions of 40 minutes each will be conducted during the 8-14 day educational hospitalization.Provide normal exercise instruction.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with type 2 diabetes who will be admitted to the Diabetes Education Hospilization at Okayama City Hospital. Patients with no history of serious circulatory disorders, osteoarticular disorders, respiratory disorders, peripheral circulatory disorders, cerebral neuropathy, severe sensory disorders, or severe visual disorders. Those who have obtained the free written consent of the research subject for participation in this study with full understanding.

Key exclusion criteria

Those with a history of serious circulatory disorder, osteoarticular disease, respiratory disease, peripheral circulatory disease, cerebral nerve disorder, severe sensory disorder, or severe visual disorder. Those with dermatitis on the thighs or those who are prone to contact dermatitis. Those who have been diagnosed by a physician as contraindicated for exercise therapy. Those who have not given their free written consent to participate in this study.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name haruka
Middle name
Last name narita

Organization

Okayama City Hospital

Division name

Department of Rehabilitation Technology

Zip code

700-8557

Address

20-1, 3-chome, Kitanagase Omote-cho, Kita-ku, Okayama City, Okayama Prefecture,JAPAN

TEL

086-737-3000

Email

pokiretsu8@gmail.com


Public contact

Name of contact person

1st name haruka
Middle name
Last name narita

Organization

Okayama City Hospital

Division name

Department of Rehabilitation Technology

Zip code

700-8557

Address

20-1, 3-chome, Kitanagase Omote-cho, Kita-ku, Okayama City, Okayama Prefecture,JAPAN

TEL

086-737-3000

Homepage URL


Email

pokiretsu8@gmail.com


Sponsor or person

Institute

Okayama City Hospital

Institute

Department

Personal name



Funding Source

Organization

Hyogo Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama City Hospital

Address

20-1, 3-chome, Kitanagase Omote-cho, Kita-ku, Okayama City, Okayama Prefecture,JAPAN

Tel

086-737-3000

Email

pokiretsu8@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 02 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2022 Year 01 Month 04 Day

Date of IRB

2022 Year 02 Month 08 Day

Anticipated trial start date

2022 Year 02 Month 20 Day

Last follow-up date

2022 Year 10 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 01 Month 29 Day

Last modified on

2023 Year 08 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053343